Item 8.01 Other Material Event

On November 23, 2022, Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. provided a Company update and recap of its concussion drug development program.

Item 7.01 Regulation FD Disclosure

Attached is a copy of a press release being issued by the Company relating to the above-referenced matter, a copy of which is attached as Exhibit as 99.1 and is hereby incorporated.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits.



Exhibit No. Description

99.1          Press Release
104         Cover Page Interactive Data File (embedded within the Inline XBRL document)








  2

© Edgar Online, source Glimpses